A detailed history of Pflug Koory, LLC transactions in Viatris Inc stock. As of the latest transaction made, Pflug Koory, LLC holds 277 shares of VTRS stock, worth $3,601. This represents 0.0% of its overall portfolio holdings.

Number of Shares
277
Previous 828 66.55%
Holding current value
$3,601
Previous $8,000 62.5%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 11, 2024

SELL
$11.27 - $13.53 $6,209 - $7,455
-551 Reduced 66.55%
277 $3,000
Q4 2023

Jan 10, 2024

SELL
$8.77 - $10.85 $254 - $314
-29 Reduced 3.38%
828 $8,000
Q3 2023

Oct 30, 2023

SELL
$9.59 - $11.35 $326 - $385
-34 Reduced 3.82%
857 $8,000
Q2 2023

Jul 21, 2023

SELL
$9.02 - $10.29 $387 - $442
-43 Reduced 4.6%
891 $8,000
Q1 2023

Apr 20, 2023

SELL
$9.2 - $12.26 $423 - $563
-46 Reduced 4.69%
934 $8,000
Q4 2022

Jan 18, 2023

SELL
$8.72 - $11.56 $1,517 - $2,011
-174 Reduced 15.08%
980 $11,000
Q3 2022

Oct 11, 2022

SELL
$8.48 - $11.13 $3,358 - $4,407
-396 Reduced 25.55%
1,154 $10,000
Q2 2022

Aug 01, 2022

SELL
$9.95 - $12.27 $10,258 - $12,650
-1,031 Reduced 39.95%
1,550 $16,000
Q1 2022

Apr 14, 2022

SELL
$9.81 - $15.4 $3,188 - $5,005
-325 Reduced 11.18%
2,581 $28,000
Q4 2021

Jan 20, 2022

SELL
$12.09 - $14.68 $3,856 - $4,682
-319 Reduced 9.89%
2,906 $39,000
Q3 2021

Oct 19, 2021

SELL
$13.25 - $15.13 $11,381 - $12,996
-859 Reduced 21.03%
3,225 $44,000
Q2 2021

Jul 14, 2021

SELL
$12.97 - $16.15 $6,238 - $7,768
-481 Reduced 10.54%
4,084 $58,000
Q1 2021

Jul 13, 2021

SELL
$13.59 - $18.54 $19,284 - $26,308
-1,419 Reduced 23.71%
4,565 $64,000
Q4 2020

Jan 14, 2021

BUY
$14.3 - $18.74 $85,571 - $112,140
5,984 New
5,984 $112,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Pflug Koory, LLC Portfolio

Follow Pflug Koory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pflug Koory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pflug Koory, LLC with notifications on news.